MIT offers glimpse of filtering's future; Roxane changes label to prevent morphine overdose;

> An MIT proof-of-concept project has shown that a polycarbonate membrane can be coated with another polymer to yield 10-nanometer pores capable of separating similar-size molecules based on their chemical properties. Article

> The FDA and Roxane Laboratories have made labeling changes to prevent accidental overdosing of patients using high-potency morphine sulfate oral solutions. News

> Contract manufacturer DSM Pharmaceutical Products will use Codexis's custom biocatalysts and services to produce the enzymes used in DSM's InnoSyn route scouting services. DSM release

> Ireland's National Cold Chain Service is stepping up deliveries of seasonal flu vaccines to doctors to ensure continuity of supply; 650,000 doses were distributed in September, 30,000 doses are in stock and 100,000 are on order. Story

> Tennessee has apparently received a shipment of the death penalty anesthetic sodium thiopental from a British drugmaker. Story

> Lupin will manufacture Farmanguinhos's four-drug tuberculosis treatment and help the company set up a local manufacturing plant in Brazil. Article

> Sun Capital Partners plans to acquire NextPharma Technologies. Item

> Adimmune says it will invest $51 million to set up Asia's largest production facility for biological agents. Article

> BioDelivery Sciences has named Steven Dykstra senior VP for manufacturing operations. BioDelivery release

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.